articleThe LancetJun 1, 2004Closed access

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

SJStevo JuliusSESverre E. KjeldsenMAMichael A. WeberHRHans R. BrunnerSESteffan Ekman

University of Michigan–Ann Arbor · State University of New York · +11 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,547
total citations
FWCI
168.10
Percentile
100%
References
41
Citations per year

Authors

14

Topics & keywords

Topics
Keywords
  • Amlodipine
  • Medicine
  • Valsartan
  • Blood pressure
  • Hazard ratio
  • Clinical endpoint
  • Internal medicine
  • Regimen
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding